Arthroscopic Repair of the Subscapularis Without Biceps Tenodesis: Early Results (SS-45)

2008 ◽  
Vol 24 (6) ◽  
pp. e25-e26
Author(s):  
John D. Kelly
2010 ◽  
Vol 26 (12) ◽  
pp. 1667-1674 ◽  
Author(s):  
Shane J. Nho ◽  
Rachel M. Frank ◽  
Stefanie N. Reiff ◽  
Nikhil N. Verma ◽  
Anthony A. Romeo

Author(s):  
Eoghan T. Hurley ◽  
Nathan A. Lorentz ◽  
Christopher A. Colasanti ◽  
Kirk A. Campbell ◽  
Michael J. Alaia ◽  
...  

2010 ◽  
Vol 2 (6) ◽  
pp. 503-508 ◽  
Author(s):  
Justin P. Strickland ◽  
Cassie M. Fleckenstein ◽  
Al Ducker ◽  
Samer S. Hasan

2021 ◽  
Vol 9 (10_suppl5) ◽  
pp. 2325967121S0033
Author(s):  
Christopher Colasanti ◽  
Eoghan Hurley ◽  
Nathan Lorentz ◽  
Kirk Campbell ◽  
Michael Alaia ◽  
...  

Objectives: The purpose of this study is to compare the outcomes of mini-open subpectoral biceps tenodesis (BT) to arthroscopic repair (AR) for SLAP tears in patients under 30. Methods: A retrospective review of patients who underwent either isolated BT or AR for the diagnosis of a SLAP tear was performed. Patients with a follow-up duration of <24 months were excluded. The American Shoulder & Elbow Surgeons (ASES) score, Visual Analogue Scale (VAS), Subjective Shoulder Value (SSV), patient satisfaction, willingness to undergo surgery again, revisions, and return to work/sport were evaluated. A p value of <0.05 was considered to be statistically significant. Results: Our study included 103 patients in total; 29 patients were treated with BT, and 74 were treated with AR. The mean age was 24.8 years, 79.4% were male, and the mean follow-up duration was 60 months. At final follow up, there was no difference between treatment groups in any of the functional outcome measures assessed (p > 0.05). Overall, there was no significant difference in the total rate of RTP (BT: 76.3%, AR: 85%; p = 0.53), timing of RTP (BT: 8.8 months, AR: 9.4 months; p = 0.61), and total rate of RTP among overhead athletes (BT: 84.2%, AR: 83.3%; p = 1). However, there was a significantly lower rate of revision surgery with BT (0%) as compared to AR (14.1%; p = 0.03). Conclusions: In patients under the age of 30 with isolated SLAP tear pathology, BT is a reliable alternative to AR, with a low rate of revision surgery, and excellent patient reported outcomes.


2005 ◽  
Vol 14 (2) ◽  
pp. 138-144 ◽  
Author(s):  
Sergio L. Checchia ◽  
Pedro S. Doneux ◽  
Alberto N. Miyazaki ◽  
Luciana A. Silva ◽  
Marcelo Fregoneze ◽  
...  

2003 ◽  
Vol 8 (4) ◽  
pp. 4-5
Author(s):  
Christopher R. Brigham ◽  
James B. Talmage

Abstract Permanent impairment cannot be assessed until the patient is at maximum medical improvement (MMI), but the proper time to test following carpal tunnel release often is not clear. The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides) states: “Factors affecting nerve recovery in compression lesions include nerve fiber pathology, level of injury, duration of injury, and status of end organs,” but age is not prognostic. The AMA Guides clarifies: “High axonotmesis lesions may take 1 to 2 years for maximum recovery, whereas even lesions at the wrist may take 6 to 9 months for maximal recovery of nerve function.” The authors review 3 studies that followed patients’ long-term recovery of hand function after open carpal tunnel release surgery and found that estimates of MMI ranged from 25 weeks to 24 months (for “significant improvement”) to 18 to 24 months. The authors suggest that if the early results of surgery suggest a patient's improvement in the activities of daily living (ADL) and an examination shows few or no symptoms, the result can be assessed early. If major symptoms and ADL problems persist, the examiner should wait at least 6 to 12 months, until symptoms appear to stop improving. A patient with carpal tunnel syndrome who declines a release can be rated for impairment, and, as appropriate, the physician may wish to make a written note of this in the medical evaluation report.


Sign in / Sign up

Export Citation Format

Share Document